Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

LLY

31 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in Eli Lilly and Company

Yes. Newedge Group holds 194,721 shares of LLY (Eli Lilly), worth $233.6M, as of its Q2 2026 13F filing. It increased the position by 10,626 shares (+5.8%) from Q1 2026. Newedge Group has held LLY in every 13F on record since Q4 2018, 31 quarterly filings. LLY is 0.7% of Newedge Group's reported 13F portfolio.

Current Value

$233.6M

Current Shares

194,721

Total Value Change

+$232.2M

Total Shares Change

+182,652

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
194,721
+5.8%
$233.6M0.7%$1,197.71
46
2026-Q1
Increased
184,095
+4.4%
$169.3M0.6%$916.88
45
2025-Q4
Increased
176,361
+39.4%
$189.5M0.7%$1,069.51
57
2025-Q3
Decreased
126,500
-0.1%
$96.5M0.4%$758.22
0
2025-Q2
Increased
126,689
+3.9%
$98.8M0.5%$772.95
44
2025-Q1
Increased
121,924
+1.0%
$100.7M0.6%$817.26
42
2024-Q4
Decreased
120,747
-1.1%
$93.2M0.6%$762.60
0
2024-Q3
Decreased
122,082
-0.9%
$108.2M0.7%$873.71
0
2024-Q2
Increased
123,167
+15.3%
$111.5M0.8%$891.63
49
2024-Q1
Increased
106,833
+7.0%
$83.1M0.7%$764.84
45
2023-Q4
Increased
99,803
+35.8%
$60.2M0.6%$572.09
54
2023-Q3
Increased
73,494
+9.0%
$39.5M0.4%$526.18
38
2023-Q2
Increased
67,451
+3.0%
$31.6M0.4%$458.43
36
2023-Q1
Decreased
65,464
-4.7%
$23.3M0.3%$334.83
0
2022-Q4
Increased
68,663
+12.3%
$11.7M0.3%$355.54
37
2022-Q3
Decreased
61,165
-2.1%
$19.8M0.3%$313.37
0
2022-Q2
Increased
62,478
+17.8%
$20.3M0.3%$313.20
40
2022-Q1
Increased
53,052
+9.9%
$15.2M0.2%$275.70
37
2021-Q4
Increased
48,278
+27.6%
$13.3M0.2%$264.82
42
2021-Q3
Increased
37,822
+18.1%
$8.7M0.2%$220.80
39
2021-Q2
Increased
32,027
+1.9%
$7.4M0.2%$218.63
33
2021-Q1
Decreased
31,435
-13.6%
$5.9M0.2%$177.17
0
2020-Q4
Decreased
36,374
-74.6%
$6.1M0.2%$159.46
0
2020-Q3
Increased
143,088
+277.1%
$21.2M0.7%$139.08
65
2020-Q2
Increased
37,943
+5.2%
$6.2M0.2%$153.51
34
2020-Q1
Increased
36,074
+16.1%
$5M0.2%$129.10
37
2019-Q4
Decreased
31,065
-0.6%
$4.1M0.2%$121.68
0
2019-Q3
Increased
31,246
+157.4%
$3.4M0.2%$102.95
51
2019-Q2
Increased
12,138
+2.0%
$1.3M0.1%$101.42
26
2019-Q1
Decreased
11,897
-1.4%
$1.5M0.1%$118.12
0
2018-Q4
First report
12,069
-
$1.4M0.1%$104.77
0

Other major holders of LLY: Lilly Endowment Inc., Vanguard Group Inc.

Optional analytics helps us improve. How it’s used